1Sentex E, Helies-Toussaint C, Rousseau D, et al. Influence of trimetazidine on the synthesis of complex lipids in the heart and other target organs[J]. Fundam Clin Pharmacol, 2001, 15(4): 255- 264.
2Monti L D, Allibardi S, Piatti P M, et al. Triglycerides impair postischemic recovery in isolated hearts: roles of endothelin-1 and trimetazidine[J].Am J Physiol Heart Circ Physiol, 2001, 281(3): H1122- 1130.
3Szwed H, Sadowski Z, Elikowski W, et al. Combination treatment in stable effort angina using trimetazidine and metoprolol: results of arandomized,double-blind, multicentrs study (TRIMPOL Ⅱ). TRIMetazidine in Pol and[J]. Eur Heart J, 2001, 22(24): 2267- 2274.
4Hanania G, Haiat R, Olive T, et al. Coronary artery disease observed in general hospitals: ETTIC study. Comparison between trimetazidine and mononitrate isosorbide for patients receiving betablockers[J]. Ann Cardiol Angeiol (Paris), 2002, 51(5): 268-274.
5Fedotkina IuA, Panchenko E P. Antiischemic efficacy of trimetazidine in patients with ischemic heart disease, stable angina pectoris and disturbances of carbohydrate metabolism[J]. Kardiologiia, 2002, 42(2): 28 - 33.
6Guler N, Eryonucu B, Gunes A, et al. Effects of trimetazidine on submaximal exercise test in patients with acute myocardial infarction[ J ]. Cardiovasc Drugs Ther, 2003, 17(4): 371 - 374.
8Tabbi Anneni I, Helies Toussain T C, Morin D, et al. Prevention of heart failure in rats by trimetazidine treatment: of accelerated phospholipid tumover[J]? Exp Ther, 2002, 304(3): 1003- 1009.
9Belardinelli R, Purcaro A. Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy [ J ]. Eur Heart J, 2001, 22 (23): 2164 -2170.
10Fragasso G, Piatti Md P M, Monti L, et al. Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy[J]. Am Heart J, 2003, 146(5): E18.
3Opie LH.Proof that glucose-insulin potassium provides metabo-lic prolection of ischemia myocardium? Lancet, 1999,353∶768-769.
4Pomin M, Harpey C, Alla J, et al.Lack of effects of trimetazidine on systemic hemodynamic in patients with coronary artery disease: a placebo-controlled study.Din Trials Meta-Anal, 1994,29∶49-56.
5Boddelce E, Hugtenhurg J, Jap W, et al.New anti-ischemic drugs: cytoprotection action with no primary hemodynamic effects.Trends pharmac Sci, 1989,10∶397-400.
